GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Hanmi Science Co Ltd (XKRX:008930) » Definitions » EV-to-EBIT

Hanmi Science Co (XKRX:008930) EV-to-EBIT : 15.80 (As of Jun. 10, 2024)


View and export this data going back to 1988. Start your Free Trial

What is Hanmi Science Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Hanmi Science Co's Enterprise Value is ₩2,333,186 Mil. Hanmi Science Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₩147,645 Mil. Therefore, Hanmi Science Co's EV-to-EBIT for today is 15.80.

The historical rank and industry rank for Hanmi Science Co's EV-to-EBIT or its related term are showing as below:

XKRX:008930' s EV-to-EBIT Range Over the Past 10 Years
Min: -1014.84   Med: 60.93   Max: 14636.33
Current: 15.8

During the past 13 years, the highest EV-to-EBIT of Hanmi Science Co was 14636.33. The lowest was -1014.84. And the median was 60.93.

XKRX:008930's EV-to-EBIT is ranked worse than
57.32% of 82 companies
in the Medical Distribution industry
Industry Median: 13.845 vs XKRX:008930: 15.80

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Hanmi Science Co's Enterprise Value for the quarter that ended in Mar. 2024 was ₩2,776,315 Mil. Hanmi Science Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₩147,645 Mil. Hanmi Science Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 5.32%.


Hanmi Science Co EV-to-EBIT Historical Data

The historical data trend for Hanmi Science Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanmi Science Co EV-to-EBIT Chart

Hanmi Science Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 66.20 156.59 70.99 30.49 20.15

Hanmi Science Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.90 24.61 20.50 20.15 18.80

Competitive Comparison of Hanmi Science Co's EV-to-EBIT

For the Medical Distribution subindustry, Hanmi Science Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hanmi Science Co's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Hanmi Science Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Hanmi Science Co's EV-to-EBIT falls into.



Hanmi Science Co EV-to-EBIT Calculation

Hanmi Science Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2333186.381/147644.559
=15.80

Hanmi Science Co's current Enterprise Value is ₩2,333,186 Mil.
Hanmi Science Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩147,645 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hanmi Science Co  (XKRX:008930) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Hanmi Science Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=147644.559/2776315.043
=5.32 %

Hanmi Science Co's Enterprise Value for the quarter that ended in Mar. 2024 was ₩2,776,315 Mil.
Hanmi Science Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩147,645 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hanmi Science Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Hanmi Science Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Hanmi Science Co (XKRX:008930) Business Description

Traded in Other Exchanges
N/A
Address
214 Muha-ro Paltan-myeon, Gyeonggi-do, Hwaseong, KOR
Hanmi Science Co Ltd is a Korea-based holding company. The company through its subsidiaries manufactures and distributes pharmaceutical products. The company offers prescription drugs such as neuropathic pain, obesity, epilepsy, lactobacillus intestinal supplement, oral care, hair growth, anti-inflammatory, schizophrenia, smoking cessation aid, diabetes, osteoporosis, antiemetic, vaginal contraceptive, expectorants, ophthalmic, immunosuppressant, prostatism, cancer, antitussives, vitamins and nutritional supplements, constipation, dermatology, among others.

Hanmi Science Co (XKRX:008930) Headlines

No Headlines